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SUMMARY
We introduce a method for computation of exact conditional efficiency robust enumeration p-values for de-
tection of genotype-phenotype associations at a single bi-allelic genetic locus. Our method can be based on
any arbitrary ranking test statistics, such as efficiency robust test statistics or asymptotic p-values. The re-
sulting p-values are exact conditional enumeration p-values and satisfy the basic statistical validity property
Pr(P ≤ α|H0) ≤ α for all parameters under the null hypothesis and all significance levels α. Practically,
the method allows performing statistically valid significance testing in genomic analyses with unknown
modes of inheritance at individual bi-allelic genetic loci – the situation typical in genome-wide association
studies. We provide an open-source R code implementing the method.
Keywords: mode of genetic inheritance; efficiency robust statistics; exact conditional inference; enumera-
tion; genome-wide association study.
1 Introduction
Genome-wide association studies (GWAS) consider hundreds of thousands of single nucleotide polymor-
phisms (SNPs) covering the entire human genome. Each SNP is normally represented by a bi-allelic locus
and assessed for association with a specific genetic trait, usually in the context of a case–control study. Com-
plex diseases such as asthma, diabetes and multiple sclerosis, among many others, are generally targeted by
GWAS in order to identify common genetic variations as potential disease risk factors. The number of ge-
netic markers in a particular GWAS can vary from several hundred thousands to several millions, depending
on the platform used for genotyping and the type of genomes to be studied. For example, more SNPs are
required for GWAS that utilize African populations than for GWAS involving European populations since
linkage disequilibrium is much lower in the former. See Manolio (2010) for an interesting well illustrated
introduction to GWAS.
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At a given genetic locus, there is a pair of markers, called alleles, inherited from each of two parents.
Given a trait is passed through this locus, there are several modes of inheritance can be in effect. The
dominant mode of inheritance requires the presence of a single ‘disease’ allele from one of parents for
a trait to be inherited. The recessive mode of inheritance requires ‘disease’ alleles from both parents to
be passed to the offspring for the trait to express. In case of the additive mode of inheritance, the trait is
expressed only partly if a single ‘disease’ allele is inherited, but express in full if both ‘disease’ alleles are
in place. There are a few more modes of inheritance can be specified depending on the degree to which the
trait is expressed in an offspring, see Visscher et al. (2008) for the discussion of heritability concepts.
When the mode of inheritance at a genetic locus is known, higher power of the test for genotype-
phenotype association can be achieved through using a Cochran-Armitage trend test (CATT) under the
explicit assumption of the specific genetic model, see Lettre et al. (2007) and Gonza´lez et al. (2008). In
practice, however, the mode of inheritance is usually unknown. Under this typical scenario, the so-called
efficiency robust tests (see Podgor et al., 1996) can be used – the group of tests that remain sensitive to
detection of genotype-phenotype associations even though the genetic model is either unknown or misspec-
ified.
There are several efficiency robust testing strategies. For example, the MAX test, first suggested by
Freidlin et al. (2002), has been recommended by several authors, see Zheng and Gastwirth (2006) and
Gonza´lez et al. (2008). This testing approach is implemented as a sequential application of several statis-
tical tests optimal for alternative genetic models with retaining the most significant result. The traditional
version of the MAX test, normally referred to as MAX3, is based on the three CATTs with scores moti-
vated by dominant, recessive and additive genetic models. Alternatively, Person’s chi-square test (χ2) can
be included within the same MAX testing strategy, leading to MAX4, see Li et al. (2009). Zheng et al.
(2009) demonstrated that χ2 test can be considered as a type of a trend test and also noted that this test is
sensitive to detection of overdominant (underdominant) modes of inheritance. MIN2 is one more variant of
the MAX test implemented as a combination of the additive CATT and χ2, see Joo et al. (2009). A slightly
different efficiency robust testing strategy is known as MERT and is a weighted version of CATT optimal
for recessive and dominant models, see Gastwirth (1985) and Freidlin et al. (2002). There are several more
efficiency robust testing approaches can be specified and some authors even suggest applying a combination
of different versions of efficiency robust tests within a single testing procedure, see Joo et al. (2009).
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In finite sample settings, many of the currently known and used efficiency robust tests are not guaranteed
to lead to statistically valid inference. This is because the underlying computational procedures are based
either on random sampling or on asymptotic distributions of efficiency robust statistics (Gonza´lez et al.,
2008; Joo et al., 2010; So and Sham, 2011). For the methods that use simulated permutations (Sladek
et al., 2007), the statistical inference will be valid, but a very high number of simulated permutations is
needed to achieve the required precision for traditionally low GWAS type significance levels (often in the
order of 10−8). Recently, Loley et al. (2013) attempted to unify the efficiency robust testing approaches by
proposing a framework also leading to inference of unknown statistical validity.
In the current paper, we introduce a computational procedure that takes as an input the ordering of
a sample space imposed by any of test statistics or p-values, including the ones introduced above. The
procedure outputs exact conditional enumeration p-values that satisfy the basic validity property Pr(P ≤
α|H0) ≤ α, for all parameters under the null hypothesis and all significance levels α.
2 Notation and the method
Let the information on a single SNP be represented by the 2 × 3 contingency table given by Table 1,
where xi and yi are the counts of observed genotypes for n1 cases and n2 controls, respectively, with
n = n1 + n2. We denote this empirically observed table by s∗(x1, x2|m1,m2, n1, n2), because all the
other entries of the table can be calculated from these numbers. Note that for given n1, n2, m1 and m2,
there is a finite number of possible contingency tables called a reference set (Verbeek, 1985) and denoted
here by S(m1,m2, n1, n2). Next let T be an arbitrary ranking statistic with the value t corresponding to the
empirically observed table s∗(x1, x2|m1,m2, n1, n2). Given a general hypothesis of ‘H0 : no association
between genotypes and the case-control status of the subjects’ tested against ‘HA : there is association
between genotypes and the case-control status of the subjects’, and larger values of T being more hostile
to the null H0, the set of tables ranked lower or equal than the observed table s∗(x1, x2|m1,m2, n1, n2) is
given by the critical set:
R(x1, x2|m1,m2, n1, n2) := {s(i, j|m1,m2, n1, n2) : T ≥ t}. (1)
By definition, a p-value is the probability of obtaining the outcome as extreme or worse than the
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Table 1: Genotype counts at a bi-allelic locus.
AA AB BB Total
Case x1 x2 x3 n1
Control y1 y2 y3 n2
Total m1 m2 m3 n
empirically observed outcome s∗(·) under the null, which is just the probability of the critical set R(·).
Under the null and based on the assumed underlying hypergeometric sampling scheme (see Lehmann
(1986) for descriptions of alternative sampling schemes), the probability of obtaining each individual table
s(i, j|m1,m2, n1, n2) within the reference set can be computed as follows:
f(i, j|m1,m2, n1, n2) =
(
m1
i
)(
m2
j
)(
n−m1−m2
n1−i−j
)
(
n
n1
) . (2)
See Lloyd (1999) for the generalization of the central multivariate hypergeometric probability function
given by (2). The p-value ps∗,T corresponding to s∗(x1, x2|m1,m2, n1, n2) is the probability of the critical
set R(·) given by (1):
ps∗,T (x1, x2|m1,m2, n1, n2) = Pr
(
R(x1, x2|m1,m2, n1, n2)
)
=
∑
s∈R
f(i, j|m1,m2, n1, n2). (3)
Note that ps∗,T is a Fisher-type conditional p-value by construction, inheriting positive (e.g. validity and
empirical relevance) as well as negative (e.g. potential conservatism and computational challenges) aspects
of Fisher’s p-values.
3 Numerical illustration
Denote statistics obtained from CATTs optimal for dominant, recessive and additive models, respectively,
by TD, TR and TA (Sasieni, 1997, p.1258):
TD =
n(nx1 − n1m1)
2
n1m1(n− n1)(n−m1)
4
TR =
n(nx3 − n1m3)
2
n1(n− n1)(nm3 −m23)
TA =
n(n(x2 + 2x3)− n1(m2 + 2m3))
2
n1(n− n1)(n(m2 + 4m3)− (m2 + 2m3)2)
All three statistics asymptotically follow the chi-square distribution with one degree of freedom. The MAX3
test statistic is given by TMAX3 = max(TD, TR, TA) with the observed value tMAX3 = max(tD, tR, tA).
For the empirically observed table s∗(0, 2|3, 4, 4, 5), the p-value ps∗,TMAX3 can be computed as shown
in Table 2. Specifically, there are 11 tables in the reference set S(3, 4, 4, 5) and only three tables in the
critical set R(0, 2|3, 4, 4, 5) given by (1). Only the tables with the values of TMAX3 statistics equally or
more extreme then observed are included in the critical set, i.e. TMAX3 ≥ tMAX3. The resulted exact
conditional efficiency robust p-value ps∗,T (0, 2|3, 4, 4, 5) = 0.0952 and is the sum of f(·|m1,m2, n1, n2)
given by (2) of the three tables in R(0, 2|3, 4, 4, 5).
Table 2: The illustrative example is based on (m1,m2, n1, n2) = (3, 4, 4, 5) with an observed value
(x1, x2) = (0, 2). The critical region R is given by the lower part of the table under the horizontal line.
x1 x2 TD TR TA TMAX3 f(x1, x2|m1,m2)
1 2 0.2250 0.0321 0.1636 0.2250 0.2857
2 1 0.9000 0.0321 0.2557 0.9000 0.1905
1 3 0.2250 2.0571 0.2557 2.0571 0.0952
2 2 0.9000 2.0571 2.0045 2.0571 0.1429
1 1 0.2250 3.2143 1.7284 3.2143 0.0952
2 0 0.9000 3.2143 0.1636 3.2143 0.0238
0 3 3.6000 0.0321 1.7284 3.6000 0.0635
0 4 3.6000 2.0571 0.1636 3.6000 0.0079
0 2 3.6000 3.2143 4.9500 4.9500 0.0476
3 0 5.6250 0.0321 2.0045 5.6250 0.0159
3 1 5.6250 2.0571 5.4102 5.6250 0.0317
ps∗,T = 0.0952
4 Conclusion
The method we suggested above is by no means new. The initial idea can be traced back to Fisher (1935)
and PS,T given by (3) is based on the combinatorial results known for many decades, see Freeman and
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Halton (1951). Our contribution to the original Fisher’s methodology is the idea of ordering the sample
space, given by the reference set S, based on any arbitrary chosen ranking statistics, the efficiency robust
test statistics in our case. We have borrowed this approach from the unconditional exact testing literature,
see Barnard (1947) and Lloyd and Moldovan (2007) for the origination of the unconditional inference
philosophy and one of the initial attempts to combine the conditional and unconditional types of exact
inference, respectively.
To conclude, it should be pointed out that only the basic form of the adjustment procedure has been
given above. In practice, more special cases can arise, such as the presence of covariates (e.g. additional
SNPs, environmental factors or baseline factors) or involvement of additional shifted parameters (e.g. in
power studies). While this is clearly the limitation of the presented procedure, the basic general exact
conditional method introduced above gives a solid basis for further investigations to these and possibly
several more theoretical and applied research directions. We provide an open-source R code to encourage
and facilitate such investigations. The R code is available upon request from the authors.
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